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Introduction {#sec001}
============

Oligomycins are macrolide antibiotics, produced by some strains of *Streptomyces*. They have broad-spectrum biological activities against organisms like fungi, bacteria, nematodes and the oomycete *Plasmopara viticola* \[[@pone.0233665.ref001]--[@pone.0233665.ref004]\]. *Streptomyces* species are common soil-dwelling bacteria that have been broadly used as bio-control agents \[[@pone.0233665.ref005]\]. *Streptomyces* species produce a number of bioactive compounds possessing antifungal, antiviral, antibacterial, anticancer, nematicidal, and antioxidant properties \[[@pone.0233665.ref005], [@pone.0233665.ref006]\]. Several previous studies showed that the effectiveness of some strains of *Streptomyces* in biological control of phytopathogens largely depends on the production of oligomycins \[[@pone.0233665.ref007]\]. The oligomycins are mitochondrial F1F0 ATP synthase inhibitors that cause apoptosis in a number of cell types \[[@pone.0233665.ref008]\]. The oligomycin complex, which was first documented in 1954 in a strain of a soil bacterium, *Streptomyces diastatochromogenes* was highly inhibitory against fungi \[[@pone.0233665.ref001]\]. Antifungal, antitumor, insecticidal, immunosuppressive and nematicidal properties of oligomycins have also been reported \[[@pone.0233665.ref001]--[@pone.0233665.ref003], [@pone.0233665.ref007], [@pone.0233665.ref009]\]. The oligomycins contain analog isomers A through G that are highly selective for disrupting mitochondrial metabolism \[[@pone.0233665.ref003], [@pone.0233665.ref004], [@pone.0233665.ref008], [@pone.0233665.ref010]\]. Although biological activities of oligomycins on fungi and the oomycete *P*. *viticola* have been reported, very little is known about the effect of these natural products on the notorious wheat blast fungus *Magnaporthe oryzae Triticum* (MoT). The bioactivities of oligomycins against different classes of fungal species indicates that their targets may involve a variety of cellular processes, such as inhibition of mycelial growth of *Cladosporium cucumerinum*, *Magnaporthe grisea*, *Colletotrichum lagenarium*, *Botrytis cinerea*, *Cylindrocarpon destructans*, *Fusarium culmorum*, *Erysiphe graminis* and *Phytophthora capsici* \[[@pone.0233665.ref003], [@pone.0233665.ref011]\], lysis and motility inhibition of *P*. *viticola*, and *Aphanomyces cochlioides* zoospores \[[@pone.0233665.ref004]\].

The wheat blast fungus MoT is one of the most destructive pathogens of wheat \[[@pone.0233665.ref012]--[@pone.0233665.ref015]\]. The three-celled, hyaline and pyriform fungal conidium attaches to the host surface by secreted adhesive \[[@pone.0233665.ref014], [@pone.0233665.ref016], [@pone.0233665.ref017]\]. The attached conidium germinates to form a hyphal germ tube, an appressorium and a penetration peg to penetrate the epidermis of the host and complete the infection process \[[@pone.0233665.ref016], [@pone.0233665.ref018]\]. The invasion of plant tissue is achieved by penetrating the epidermal cells and invaginating the host plasma membrane \[[@pone.0233665.ref016]--[@pone.0233665.ref018]\]. The fungus can attack wheat plants at any stage of development and infects leaves, nodes, stems, and spikelets \[[@pone.0233665.ref015], [@pone.0233665.ref017], [@pone.0233665.ref019]\]. Mycelium can survive in the embryo, endosperm, and kernal tissues of wheat seed. Wheat blast mainly affects wheat heads; it bleaches the infected heads, resulting in deformed seed or no seed production \[[@pone.0233665.ref014]\]. The badly affected wheat heads can die, leading to a drastic reduction in grain yield. Bleaching of the spikelets or the entire head at an early stage is the most common recognizable symptom of the disease \[[@pone.0233665.ref012], [@pone.0233665.ref014], [@pone.0233665.ref015]\]. Infected seeds and airborne conidia usually disseminate the fungus which may survive in infected seeds and crop residues \[[@pone.0233665.ref020]\]. Pyriform conidia developed from conidiophores and conidia germination with appressorial development at the germ tube tips are essential steps of the disease cycle of MoT \[[@pone.0233665.ref016]\]. Disruption of any of these asexual life stages reduces the chance of pathogenesis and development of an epidemic \[[@pone.0233665.ref021]\]. Finding natural bioactive compounds capable of inhibiting any of these asexual life stages is considered the first step in the development of a new fungicide for controlling MoT.

Wheat blast was first found in Brazil in 1985, and subsequently spread to neighboring Bolivia and Paraguay \[[@pone.0233665.ref012], [@pone.0233665.ref019]\]. The cultivation of wheat (*Triticum aestivum*) has increased in Bangladesh in recent years making it the 2^nd^ largest food source after rice. A sudden outbreak of wheat blast occurred in Bangladesh in 2016, which was the first incident of wheat blast outside of South America \[[@pone.0233665.ref014], [@pone.0233665.ref022]\]. About 15,000 hectares of wheat were destroyed, resulting in about 15% crop losses in Bangladesh \[[@pone.0233665.ref014]\]. The outbreak concerned crop scientists as it has the potential to extend further to major wheat-producing regions in neighboring South Asian countries and Africa due to similar climatic conditions \[[@pone.0233665.ref023]\]. Plant pathologists have cautioned that this disease is expected to disperse to India, Pakistan and China, that rank 2^nd^, 8^th^ and 1^st^, respectively, in the world for wheat production, \[[@pone.0233665.ref015], [@pone.0233665.ref024]\].

Current wheat blast disease management methods include the utilization of synthetic fungicides. Natural products generally impart less harmful effects on the environment and health of living species including humans when compare to their synthetic contemporaries \[[@pone.0233665.ref025], [@pone.0233665.ref026]\]. Indiscriminate application of synthetic commercial fungicides for plant protection may also result in development of resistance in fungal population to fungicides \[[@pone.0233665.ref013], [@pone.0233665.ref017]\]. In Brazil and other South American countries, some MoT strains have developed resistance to strobilurin (QoI) and triazole fungicides \[[@pone.0233665.ref027], [@pone.0233665.ref028]\]. Nowadays, natural products that are environment-friendly with minimum toxicity to living organisms are gaining popularity as important ecologically suited alternative fungicides for protecting plants. Therefore, search for novel bioactive natural products against MoT is an urgently needed scientific endeavor.

The biological approach for plant disease management offers a better alternative to the control of wheat blast. There is very little information available on the antagonistic effects of *Streptomyces* spp., and/or secondary metabolites derived from them to control wheat blast. We screened 150 natural compounds belonging to the classes alkaloids, terpenoids, macrolides, macrotetrolides, tepenoids, and phenolics isolated from different plants and microorganisms for antagonistic activity against MoT in our laboratory \[[@pone.0233665.ref021]\]. Among them, the two most potential macrolides, oligomycin B and oligomycin F, previously extracted from the marine *Streptomyces* spp. \[[@pone.0233665.ref003]--[@pone.0233665.ref004]\] were selected for this study. The specific objectives of this study were to: (i) test the effect of oligomycin B and F on the inhibition of mycelial growth of MoT; (ii) examine their effect on conidiogenesis, conidial germination and subsequent morphological development; (iii) evaluate the suppression of wheat blast disease using detached wheat leaves; and iv) compare the efficacy of these two oligomycins with a local standard fungicide product.

Materials and methods {#sec002}
=====================

Chemicals {#sec003}
---------

Oligomycin B and oligomycin F ([Fig 1](#pone.0233665.g001){ref-type="fig"}) were isolated from the marine bacteria, *Streptomyces* sp. strains B8496, B8739 and A171 \[[@pone.0233665.ref003]--[@pone.0233665.ref004]\]. These pure compounds were generously provided by Dr. Hartmut Laatsch of Georg-August University Goettingen, Germany. The fungicide Nativo® WG 75 (a combination of tebuconazole, 50% and trifloxystrobin, 25%) was purchased from Bayer Crop Science Ltd. Dhaka, Bangladesh.

![Structures of oligomycin B and F.](pone.0233665.g001){#pone.0233665.g001}

Fungal strain, growth media and plant materials {#sec004}
-----------------------------------------------

The strain BTJP 4 (5) of MoT was isolated from blast infected spikelets of wheat cv. BARI Gom-24 (Prodip) in Jhenaidah, Bangladesh in 2016. For this research a pure culture from a single spore was preserved at 4°C on dry filter paper \[[@pone.0233665.ref014]\]. The isolate (BTJP 4) was re-cultured on Potato Dextrose Agar 42 g/L (PDA) at 25°C for 7 days. Ten-day-old fungal cultures grown on PDA were washed in an aseptic environment in a laminar flow hood with 500 ml of deionized distilled water to remove aerial mycelia; then kept at ambient room temperature (25--30°C) for 2--3 days to induce abundant conidia production \[[@pone.0233665.ref014], [@pone.0233665.ref029]\]. Conidia were scraped from the plates with a glass slide after adding 15 ml water into each plate. The conidial and mycelial suspension was filtered through two layers of cheese cloth and adjusted to a concentration of 1 × 10^5^ conidia/ml. Conidial germination was visualized and counted under a compound microscope. Wheat blast susceptible, five-leaf stage seedlings of cultivar BARI Gom-24 (Prodip) was used for the leaf bioassay \[[@pone.0233665.ref030]\].

Inhibition of mycelial growth and morphological effects on hyphae {#sec005}
-----------------------------------------------------------------

A modified disk diffusion technique \[[@pone.0233665.ref031]\] was used to determine hyphal growth suppression of MoT isolate BTJP by the oligomycins and the commercial fungicide, Nativo ® WG. A series of concentrations ranging from 0.005 to 2 μg / disk of the oligomycins and the fungicide Nativo ® WG75 were prepared by dissolving required amounts in ethyl acetate and water, respectively. Filter-paper disks (Sigma-Aldrich Co., St. Louis, MO, USA) measuring nine-millimeter diameter were soaked with the test compounds. The treated disks were placed 2 cm from one side of 9 cm dia Petri dishes containing 20 ml PDA. Five-millimeter diameter mycelial plugs from actively growing seven-day-old PDA cultures of MoT were placed on the opposite side of filter paper disk containing test compounds. Petri dishes inoculated with fungal mycelial plugs against fungicide Nativo ® WG75 were used as an industry standard. Filter paper disks treated with ethyl acetate followed by evaporation of ethyl acetate in room temperate served as a negative control. Inhibition of fungal growth was apparent within 10 days of incubation. Plates were incubated at 25°C until the fungal colony fully covered the agar surface of the control plates. There were five replications for each concentration and the experiment was repeated five times. The fungal colony\'s radial growth was measured in centimeters with a ruler along with two perpendicular lines drawn on each plate\'s lower side. Data were recorded by measuring the inhibition zone created by test compounds and corresponding mycelial growth. Radial growth inhibition percentage (RGIP) (± standard error) \[[@pone.0233665.ref032]\] was calculated from mean values as: $$RGIP\ \left( \% \right) = \ \frac{Radial\ growth\ in\ control\ plate - Radial\ growth\ in\ treated\ plate}{Radial\ growth\ of\ control} \times 100$$

Hyphal morphology at the leading edge of the colonies facing the treated and control disks were observed with a Zeiss Primo Star microscope at 40X and 100X (100x was an oil emersion lens). Images of the disk diffusion experiment were captured with a Canon DOS 700D digital camera. Images of the hyphae were captured with a Zeiss Axiocam ERc 5s through the microscope.

Inhibition of conidiogenesis {#sec006}
----------------------------

Stock solutions of each of the oligomycins were prepared in 10 μl of dimethyl sulfoxide (DMSO). Stock solution was then diluted with distilled water to obtain 5, 10 and 100 μg / ml concentrations. The final concentration of DMSO was never higher than 1% (v / v) in the final solution, which does not affect the hyphal growth or sporulation of MoT. Preparation of 5 ml fungicidal suspension of Nativo®WG75 at 5, 10 and 100 μg/ml concentrations was carried out by mixing the required amount of product in distilled water for using it as a positive control. Mycelium of a 10-day-old Petri dish culture of MoT was washed to reduce nutrients and induce conidiogenesis \[[@pone.0233665.ref014], [@pone.0233665.ref029]\]. Ten mm MoT mycelial agar blocks were treated with 50 μl of each compound and Nativo®WG75 at 5, 10 and 100 μg/ml and put into Nunc multi well plates. The same amount of sterile water was applied on the MoT mycelial block with 1% DMSO serving as a negative control. Treated mycelial agar blocks MoT were incubated at 28°C with \>90% RH and 14 h light followed by 10 h of darkness. After 24 hours, conidiogenesis was observed with a Zeiss Primo Star microscope at 40x magnification and images captured with a Zeiss Axiocam ERc 5s. There were five replications per treatment and the experiment was conducted five times.

Inhibition of conidial germination and morphological changes of germinated conidia {#sec007}
----------------------------------------------------------------------------------

A stock solution of each oligomycin was prepared by dissolving 0.1 μg of the compound in 10 μl dimethyl sulfoxide (DMSO) followed by diluting the concentration. of each compound to 0.1μg/ml by adding distilled water. Nativo®WG75 solution was prepared with distilled water at 0.1 μg/ml to use as a positive control. Conidial germination assays were carried out following the protocol described by Islam and von Tiedemann \[[@pone.0233665.ref033]\]. For each treatment, a 100 μl solution of 0.1 μg/ml was added directly to 100 μl of 1 × 10^5^ conidia/ml of MoT to make a final volume of 200 μl containing 0.05 μg/ml test compound into a well of a 96-multiwell plate. The solution was mixed immediately with a glass rod and incubated at 25°C. Sterilized water with 1% DMSO served as a control. The multiwell plate was incubated in a moisture chamber at 25 ^0^C for 6 h, 12 h and 24 h in the dark. A total of 100 conidia from each of five replicates were examined under a Zeiss Primo Star at 100x magnification. Percent germination of conidia and developmental differences of the germ tubes and appressoria were evaluated and the images were captured with a Zeiss Axiocam ERc 5s. Each treatment and time course was replicated five times and the experiments repeated five times. The percent conidial germination (± standard error) was calculated from mean values as: CG % = (C--T)/C × 100; Where, CG = conidial germination, C = percentage of germinated conidia in control, and T = percentage of germinated conidia in treated samples.

Development of wheat blast on detached wheat leaves {#sec008}
---------------------------------------------------

Stock solutions of oligomycins B and F were prepared using dimethyl sulfoxide (DMSO). Then preparation of 5, 10 and 100 μg/ml concentrations of each compound was carried out in distilled water where the final concentration of DMSO never exceeded 1%. Nativo®WG75 concentrations were 5, 10 and 100 μg/ml. Sterilized water with 1% DMSO served as a negative control. Wheat leaves were separated from five-leaf stage seedlings and placed in plates lined with moist paper towels. Three 20-μl droplets of the freshly prepared test compounds at concentrations mentioned above were placed on three different spots of each leaf, and left for 15 minutes to dry. Each spot was then inoculated with 1 μl conidial suspension containing 1 × 10^5^ MoT conidia/ml followed by incubating dishes at 28°C under 100% relative humidity in dark for first 30 h, then 2 days in continuous light. The test was performed five times independently with 5 replicate samples. The resulting length of wheat blast lesions MoT were measured from 3 leaves per experiment for each treatment and each concentration of compounds.

Statistical analysis, experimental design/replications {#sec009}
------------------------------------------------------

Experiments were performed using a completely randomized design (CRD) to determine biological activities of the pure oligomycin compounds compared to a standard fungicide. Data were analyzed by one-way ANOVA, and mean values were separated by the posthoc statistic of Tukey\'s HSD (honest significant difference). All statistical analyses were carried out with SPSS (IBM SPSS statistics 16, Georgia, USA) and Microsoft Office Excel 2010 program package. Mean value ± standard error of 5 replications were used in Tables and Figures.

Results {#sec010}
=======

Inhibition of mycelial growth and morphological effects on hyphae {#sec011}
-----------------------------------------------------------------

Both oligomycins B and F ([Fig 1](#pone.0233665.g001){ref-type="fig"}) tested in this study and originally extracted from a *Streptomyces* species showed significant inhibition of MoT hyphal growth on PDA ([Fig 2](#pone.0233665.g002){ref-type="fig"}). Between these two compounds, oligomycin F depicted stronger inhibition of hyphal growth of MoT. Mycelial growth inhibition by oligomycins B and F was 57.1 ± 1.3% and 73.9 ± 2.5%, respectively when both compounds were used at 2 μg/disk ([Fig 3](#pone.0233665.g003){ref-type="fig"}) The commercial fungicide Nativo® WG 75 had a higher inhibition capacity (81.9 ± 0.9% at 2 μg/disk) than both oligomycin F and B.

![Macroscopic and microscopic images of *in vitro* antifungal activity of oligomycin B, oligomycin F and the commercial fungicide nativo® WG75 against *Magnaporthe oryzae Triticum* at 2 μg/disk; (a) Control, (b) Oligomycin B, (c) Oligomycin F, (d) Nativo® WG75. Bar = 10 μm, 50 μm.](pone.0233665.g002){#pone.0233665.g002}

![Inhibitory effects of oligomycin B, oligomycin F and the commercial fungicide Nativo® WG75 on hyphal growth of *Magnaporthe oryzae Triticum* in potato dextrose agar.\
The data are the mean ± standard errors of five replicates for each concentration of the compound tested at a 5% level based on the Tukey HSD (Honest Significance Difference) post-hoc statistic.](pone.0233665.g003){#pone.0233665.g003}

Both oligomycins inhibited MoT mycelial growth in a dose dependent manner. Suppressive effects of oligomycin increased with increasing concentrations from 0.005 to 2 μg/disk reaching 74% for oligomycin F ([Fig 3](#pone.0233665.g003){ref-type="fig"}). Suppression by oligomycin F was slightly lower than suppression by Nativo® WG 75 but higher than oligomycin B. Neither of the oligomycins showed activity against MoT at concentration lower than 0.005 μg. Oligomycin F showed extensive inhibition of hyphal growth at 2 μg/disk (73.9 ± 2.5%) followed by 1.5 μg/disk (67.6 ± 0.9%) and 1 μg/disk (60.9 ± 2.5%) showing a positive correlation of suppression with an increase in concentration. The percent suppression by oligomycin B was 57.1 ± 1.3%, 54.3 ± 1.3% and 53.3 ± 1.5%, at 2, 1.5 and 1 μg/disk, respectively. The minimum inhibitory concentrations of oligomycin F and oligomycin B were 0.005 and 0.05 μg/disk, respectively. At the minimum inhibitory concentrations, hyphal growth inhibition was 11.4 ± 2.3% and 8.63 ± 1.3%, respectively for oligomycin F and B. The minimal inhibitory concentration of Nativo® WG 75 was 0.05 μg/disk, similar to oligomycin B although fungicide at higher concentration starting from 0.25 μg/disk superseded inhibition percentage at equivalent concentrations of oligomycins. It is interesting to note that at concentrations below 0.25 μg/disk, the inhibition of mycelial growth by oligomycin F was higher than that of the fungicide Nativo® WG 75 and this macrolide displayed inhibitory activity against MoT at about 10-fold lower concentration.

Microscopic observations showed that untreated MoT hyphae had polar, tubular growth with smooth, branched, hyaline, plump, septate, and intact hyphae ([Fig 2A](#pone.0233665.g002){ref-type="fig"}). Hyphae treated with oligomycin B and F showed irregular growth and an increase in branch frequency per unit length of the hyphae. The hyphal cell walls were not smooth but showed ridges giving a corrugated appearance and irregular swelling of cells ([Fig 2B and 2C](#pone.0233665.g002){ref-type="fig"}). Nativo ® WG75 showed a similar pattern of hyphal growth inhibition. Similar abnormality of MoT also occurred where the hyphae were close to the Nativo ® WG75 disk ([Fig 2D](#pone.0233665.g002){ref-type="fig"}). However, morphological changes of MoT by the two oligomycins were slightly different from those observed with the Nativo®WG75 suggesting a possible different mode of action.

Inhibition of conidiogenesis {#sec012}
----------------------------

Conidial formation by MoT was remarkably decreased by the oligomycins and the fungicide at 5 and 10 μg/ml when compared to the control, and inhibition increased with an increase in concentration from 5, 10 and 100 μg/ml ([Fig 4](#pone.0233665.g004){ref-type="fig"}). For all three treatments, no conidia developed at 100 μg/ml. Microscopic examination revealed broken mycelial tips, and a complete lack of conidiophores for all three treatments at 100 μg/ml.

![Effects of oligomycin B, oligomycin F and the fungicide Nativo® WG75 on inhibition of conidiogenesis of *Magnaporthe oryzae Triticum* in 96-multiwell plates at 5 μg/ml, 10 μg/ml, 100 μg/ml.\
(a) Control, (b) Oligomycin B, (c) Oligomycin F, (d) Nativo® WG75. Bar = 50 μm.](pone.0233665.g004){#pone.0233665.g004}

Inhibition of conidial germination and morphological changes of germinated conidia {#sec013}
----------------------------------------------------------------------------------

Oligomycin B, F and Nativo ® WG75 at 0.05 μg/ml were used to determine the inhibition of conidial germination of MoT in multi-well plates. After 6, 12 and 24 h of incubation, the percent of germinated conidia was recorded ([Table 1](#pone.0233665.t001){ref-type="table"}). After 6 h, all three treatments significantly reduced germination of conidia compared to the control. Germination was 100% in water, and 50.3±0.7% in plates treated with Nativo ® WG75. With oligomycin B and F germination percentages of MoT conidia were 24 ± 0.9% and 53±0.4% at 0.05 μg/ml, respectively.

10.1371/journal.pone.0233665.t001

###### Effects of oligomycins and the fungicide Nativo® WG75 on germination of conidia and morphology of germ tubes and appressoria of *Magnaporthe oryzae Triticum* at 0.05 μg/ml *in vitro*.

![](pone.0233665.t001){#pone.0233665.t001g}

  Compound       Time (h)   Germination of conidia, and morphology of germ tubes and appressorial formation   
  -------------- ---------- --------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------
  Water          0          0 ± 0e                                                                            No germination
                 6          100 ± 0a                                                                          Germination with normal germ tube and normal appressoria
                 12         100 ± 0a                                                                          Normal mycelial growth
                 24         100 ± 0a                                                                          Normal mycelial growth
  Oligomycin B   0          0 ± 0e                                                                            No germination
                 6          38.3 ± 0.7d                                                                       24 ± 0.9% Short germ tube and 14.3 ± 0.7% conidia lysed
                 12         24 ± 0.9d                                                                         10.6 ± 0.7% Normal germ tube, 8.4 ± 0.2% short and 5 ± 0.4% Abnormally elongated germ tube
                 24         0 ± 0b                                                                            No appressoria, no mycelial growth
  Oligomycin F   0          0 ± 0e                                                                            No germination
                 6          59 ± 0.8b                                                                         53 ± 0.4% Short germ tube and 6 ± 0.8% conidia lysed
                 12         53 ± 0.4b                                                                         33.3 ± 0.5% Normal germ tube and 19.7 ± 0.2% abnormal branching at the tips
                 24         0 ± 0b                                                                            No appressoria, no mycelial growth
  Nativo         0          0 ± 0e                                                                            No germination
                 6          50.3 ± 0.7c                                                                       Germinated with a short germ tube
                 12         50.3 ± 0.7c                                                                       Normal germ tube
                 24         0 ± 0b                                                                            No appressoria; no mycelial growth

^a^The data presented here are the mean value ± SE of three replicates in each compound. Means within the column followed by the same letter(s) are not significantly different from those assessed by Tukey\'s HSD (Honest Significance Difference) post-hoc (p ≤ 0.05). Conidia germination percent at different incubation times is not cumulative, rather at different time intervals.

Conidial germination in water was 100% with normal germ tube development and mycelial growth at all incubation times (6 h, 12 h and 24 h) at 25°C in dark ([Table 1](#pone.0233665.t001){ref-type="table"}, [Fig 5A](#pone.0233665.g005){ref-type="fig"}). The two oligomycins had adverse effects not only on conidial germination but also post-germination developmental processes with abnormal transitions from one step to the next at 0.05 μg/ml. Out of 38% of the germinated spores in the oligomycin B treatment, 24 ± 0.9% had short germ tubes and 14.3± 0.7% of the germ tubes lysed within the first 6 h of incubation. After 12 h of incubation in the same treatment, out of 24% germinated spores, 10.6 ± 0.7% were normal, 8.4 ± 0.2% had shorter germ tubes than the control and 5 ± 0.4% had abnormally elongated germ tubes. After 24 h of incubation, no conidia germinated ([Table 1](#pone.0233665.t001){ref-type="table"}, [Fig 5B](#pone.0233665.g005){ref-type="fig"}). In the presence of oligomycin F, 53 ± 0.4% of conidia germinated with shorter germ tubes than the control and 6 ± 0.8% conidia lysed after 6 h. Similar developmental abnormalities were found among the germinated conidia after 12 h of incubation with 33.3 ± 0.5% normal and 19.7 ± 0.2% with abnormally branched germ tubes formation, while no germination after 24 h ([Table 1](#pone.0233665.t001){ref-type="table"}, [Fig 5C](#pone.0233665.g005){ref-type="fig"}). In the presence of Nativo® WG75, 50.3 ± 0.7% conidia germinated with normal germ tubes after 6h and 12 h, but no appressoria developed. Nativo® WG75 also prevented spore germination after 24 h ([Table 1](#pone.0233665.t001){ref-type="table"}, [Fig 5D](#pone.0233665.g005){ref-type="fig"}). It is interesting that the oligomycins produced abnormally long or short or branched germ tubes and lysing of conidia, while the fungicide did not result in these changes.

![Time-dependent alterations in *Magnaporthe oryzae Triticum* germination of conidia and subsequent morphological changes in the presence of oligomycin B, oligomycin F and the commercial fungicide Nativo® WG75.\
Dose of oligomycins was 0.05 μg/ml. (a) Control, (b) Oligomycin B, (c) Oligomycin F, (d) Nativo® WG75. Branched germ tube (*arrow*); Elongated germ tube (*arrow*); Lysis of conidia (*arrow head*). Bar = 10 μm.](pone.0233665.g005){#pone.0233665.g005}

Development of wheat blast on detached wheat leaves {#sec014}
---------------------------------------------------

Application of the two oligomycins at 5, 10 and 100 μg/ml remarkably inhibited symptoms of wheat blast in detached wheat leaves, inoculated with MoT. The average length of lesions in the wheat leaves treated with oligomycin B were 6.3 ± 0.3 mm and 1.8±0.3 mm at 5μg/ml and 10 μg/ml, respectively ([Fig 6A and 6B](#pone.0233665.g006){ref-type="fig"}). With oligomycin F and Nativo®WG75, blast lesion lengths were 4 ± 0.3 mm and 2 ± 0.3 mm at 5 μg/ml, respectively ([Fig 6A and 6B](#pone.0233665.g006){ref-type="fig"}). No blast symptoms were visible when leaves were treated with oligomycin F and the fungicide Nativo®WG75 at 10 μg/ml and 100 μg/ml ([Fig 6A and 6B](#pone.0233665.g006){ref-type="fig"}). No visible blast lesion occurred when treated with oligomycin B at 100 μg/ml. Leaves treated with water as a negative control developed typical blast lesions with an average length of 9.58 ± 0.2 mm ([Fig 6A and 6B](#pone.0233665.g006){ref-type="fig"}). These results show that the fungicide suppressed lesion development more than both oligomycins at 5 μg/ml, the fungicide showed more suppression than oligomycin F at 10 μg/ml, and no lesions developed with any of the three treatments at 100 μg/ml.

![Suppression of wheat blast symptoms with oligomycins at 5 μg/ml, 10 μg/ml and 100 μg/ml on a representative detached wheat leaf of five replicates inoculated with *Magnaporthe oryzae Triticum* (A) blast lesions on treated and untreated wheat leaves (a) Water control+MoT, (b) Oligomycin B+MoT inoculation, (c) Oligomycin F+MoT inoculation, (d) Nativo® WG75+MoT inoculation, (e) Non-inoculated, non-treated leaf; (B) Blast lesion lengths on detached wheat leaves treated with oligomycin B oligomycin F and Nativo ® WG75 fungicide compared with water treatment control. The data are the averages ± standard errors of at least five replicates for each dose of the tested compounds at p ≤ 0.05. Bars represent ± standard error.](pone.0233665.g006){#pone.0233665.g006}

Discussion {#sec015}
==========

In this study, we found that two *Streptomyces* macrolides, oligomycin B and oligomycin F, demonstrated extensive antifungal activities against the devastating wheat blast pathogen of wheat. Of the two oligomycins tested, biological activity of oligomycin F was superior than oligomycin B and in some cases, superior to the commercial fungicide Nativo® WG75. These findings indicate that suppression of conidial germination, appressorial formation and mycelial growth by these macrolides are correlated with wheat blast disease suppression on inoculated leaves. Hyphal growth inhibition, conidial formation and germination of conidia of various fungi including the rice blast fungus (MoO) by a number of natural secondary metabolites from *in vitro* bioassays have been documented by many investigators \[[@pone.0233665.ref003], [@pone.0233665.ref011], [@pone.0233665.ref034]--[@pone.0233665.ref039]\]. To the best of our knowledge, this is the first report of suppression of the devastating wheat blast fungus by oligomycin B and F isolated from the *Streptomyces* spp., with the potential to be utilized for managing the disease *in vivo*.

Oligomycins are macrolide antibiotics that block the proton channel (F0 subunit) requisite for the oxidative phosphorylation of ADP to ATP due to inhibition of ATP synthase. \[[@pone.0233665.ref040]\]. While oligomycins have excellent biological properties, only a few studies have so far focused on the development of plant disease protection products from these macrolides. Interestingly, our result also revealed that the efficacy of oligomycin F in controlling wheat blast fungus was 10-fold stronger than the commercial fungicide Nativo ® WG75 in terms of mycelial growth inhibition.

One of the noteworthy findings from the present study is the induction of swelling on the MoT hyphae by these macrolides ([Fig 2B and 2C](#pone.0233665.g002){ref-type="fig"}), which is often considered as a reliable mode of inhibitory action of a compound against the normal growth and development of a fungal pathogen \[[@pone.0233665.ref038], [@pone.0233665.ref039]\]. We tested a range of concentrations of these compounds from 0.005 to 2 μg /disk, and found that swelling in hyphae increased with increasing concentrations of the oligomycins (data not shown). Swelling in various fungal hyphae has been reported earlier by polyoxin B \[[@pone.0233665.ref041]\], fengycin \[[@pone.0233665.ref037]--[@pone.0233665.ref039]\] and tensin \[[@pone.0233665.ref042]\]. Morphological changes like extensive branching and swelling of hyphae of an oomycete pathogen *Aphanomyces cochlioides* by phloroglucinols extracted from *Pseudomonas fluorescence* or xanthobaccin A isolated from *Lysobacter* sp. SB-K88 have been documented \[[@pone.0233665.ref043]--[@pone.0233665.ref046]\]. According to a report by Kim et al. \[[@pone.0233665.ref011]\], oligomycin A from *Streptomyces libani*, significantly inhibited mycelial growth of *Magnaporthe grisea*, *Botrytis cinerea*, *Colletotrichum lagenarium*, *Cylindrocarpon destructans*, *Cladosporium cucumerinum and Phytophthora capsici*. So far, this is the first report of swollen-like structures development in hyphae by oligomycins toward the destructive phytopathogen, MoT. Further investigation is needed to understand the detailed modes of action of these macrolides towards suppression of the phytopathogen, MoT.

Conidia are the infecting propagule by which most pathogenic fungi invade plants and the process by which conidia are formed is known as conidiogenesis \[[@pone.0233665.ref035], [@pone.0233665.ref047]\]. The more conidia a fungal pathogen produces the more its potential to destroy a plant, which is very significant in case of an economically important cereal crop like wheat. Inhibition of conidiogenesis and conidial germination reduces the chance of secondary infection. Compounds that are found to inhibit these processes are great candidate for downstream application as plant protection products. A few interesting findings of this study showed that both oligomycin B and F not only strongly suppressed conidiogenesis ([Fig 4](#pone.0233665.g004){ref-type="fig"}), but also inhibited germination of conidia and further morphological advancement of the germ tube towards hyphal growth ([Table 1](#pone.0233665.t001){ref-type="table"}, [Fig 5](#pone.0233665.g005){ref-type="fig"}). Results from the bioassay showed that wheat leaves prophylactically treated with these macrolides at 5, 10 and 100 μg/ml had restricted fungal growth and limited disease development. Other novel and interacting phenomena observed in this study included lysis of conidia, irregular branching of the tip of germ tube, and abnormally elongated hypha-like germ tubes ([Fig 5B and 5C](#pone.0233665.g005){ref-type="fig"}). Similar phenomenon was observed by Dame et al., \[[@pone.0233665.ref004]\] who reported that oligomycin A, B and F from a marine *Streptomyces* could induce lysis of zoospores of the plant pathogen *Plasmopara viticola*, which causes grapevine downy mildew. Homma et al. \[[@pone.0233665.ref048]\] reported that lecithin induced abnormal branching at the conidial germ tube tips and inhibited appressoria formation of rice blast fungus. Islam and Fukushi \[[@pone.0233665.ref046]\] reported that cystospores of *A*. *cochlioides* produced in the presence of diaacetylphloroglucinol (DAPG) subsequently germinated with hyperbranched germ tubes. Modes of action and mechanism of inhibition of conidiogenesis, germination and formation of appressoria of the MoT conidia by oligomycins has not been previously reported.

Oligomycins are macrolide antibiotics that impede ATP production by influencing oxidative phosphorylation in mitochondria \[[@pone.0233665.ref049]\]. The oligomycin comprises a 26-membered α, β-unsaturated lactone with a conjugated diene fused to a bicyclic spiroketal ring system. Their mode of action includes the decoupling of mitochondrial ATPase F0 and F1 factors responsible for promoting the transfer of proton via the inner mitochondrial membrane \[[@pone.0233665.ref050]\]. The enzymatic complex F0F1 ATP synthase may be considered as a target for antifungal and anti-tumor or anti-infection therapy \[[@pone.0233665.ref051]\]. Oligomycins display a number of important biological activities including mitochondrial ATPase inhibition, strong antifungal, anti-actinobacterial and anti-tumor effects that have been reported \[[@pone.0233665.ref009], [@pone.0233665.ref001], [@pone.0233665.ref051]\]. These natural products are among the strongest selective agents in the cell line; they interrupt P-glycoprotein activity and induce apoptosis in doxorubicin-resistant HepG2 cells \[[@pone.0233665.ref052]\]. Oligomycins have a variety of isomers called oligomycin A through G. These are particularly relevant to the disruption of mitochondrial metabolism \[[@pone.0233665.ref010]\]. Moreover, elucidation of structure has provided new horizons for developing new ATP synthase-directed agents with possible therapeutic effects \[[@pone.0233665.ref053]\]. The first reports of chemical modification of oligomycin A have already been documented by Lysenkova et al. \[[@pone.0233665.ref054]\]. New compounds also showed efficacy against *Candida albicans*, *Aspergillus niger* and *Cryptococcus humicolus*, with other biological properties similar to those of oligomycin A, but with less cytotoxic effects. During germination, conidia might need a constant energy (ATP) supply from the internal energy reserve of the cells \[[@pone.0233665.ref055]\]. Therefore, a plausible explanation for the suppression of hyphal growth and conidia germination of MoT demonstrated in this study is likely to be associated with ATP synthesis inhibition in mitochondria due to the effects of oligomycins. More studies are required to determine the precise structure-activity relationships of these oligomycins, which may make it possible to synthesize a more active oligomycin as an effective agrochemical against MoT.

A hallmark finding of this study is that application of both macrolides significantly inhibited blast disease development in detached leaves of wheat ([Fig 6](#pone.0233665.g006){ref-type="fig"}). In this study, wheat leaves treated with oligomycin B and F had shorter lesion lengths than the untreated control ([Fig 6](#pone.0233665.g006){ref-type="fig"}). Many of the lesions in treated leaves were small brown in color with pinhead-sized specks (scale 1) to small, roundish to slightly elongated infecting \<10% of wheat leaf area (scale 5). In contrast, water treated control leaves had typical blast lesions infecting more than 75% wheat leaf area (scale 9) corresponding to scale 9 of blast disease assessment scale provided by the IRRI Standard Evaluation System \[[@pone.0233665.ref056]\]. However, no blast lesions were visible on the leaves treated with the oligomycin compounds and Nativo ® WG75 at the highest concentration ([Fig 6](#pone.0233665.g006){ref-type="fig"}). Nativo ® WG75 is a systemic wide-spectrum commercial fungicide that we used as a positive control. Interestingly, the antifungal effect of oligomycins on the inhibition of MoT fungus was found equivalent or stronger than that of the fungicide. Tebuconazole and trifloxystrobin are two main active ingredients of Nativo ® WG75. Tebuconazole is known as a demethylase inhibitor (DMI), which is a systemic triazole fungicide. Demethylase inhibitors inhibit ergosterol biosynthesis, which is a major component of the plasma membrane of certain fungi essential for growth and further development of the fungus \[[@pone.0233665.ref057]\]. Trifloxystrobin is a strobilurin fungicide that interferes with the respiration of plant pathogenic fungi by preventing energy production in mitochondria, thereby inhibiting germination of fungal conidia \[[@pone.0233665.ref058]\]. The mechanisms of disease suppression by the oligomycins are likely different compared with the mechanisms of Nativo ® WG75 although similar disease suppression effect has been obtained. Further study is needed to elucidate the underlying mechanism of wheat blast disease suppression by the oligomycin B and F. Furthermore, a field trial of the oligomycins in controlling wheat head infection is needed before considering them as effective fungicides against the wheat blast.

Despite their significant potency as antifungal compounds, little information is available on the effectiveness of oligomycins as agricultural fungicides. The shorter residual effect of oligomycin can be important in the reduction of deleterious effects on humans and the environment, considering that sufficient efficacy in the management of plant diseases is sustained \[[@pone.0233665.ref011]\]. Oligomycin A was found the most active anti-filamentous fungal analogue among antibiotics in the oligomycin family \[[@pone.0233665.ref001], [@pone.0233665.ref059], [@pone.0233665.ref060]\]. As oligomycin F is the immunosuppressive homolog of oligomycin A \[[@pone.0233665.ref003]\], and oligomycin B is a stable natural product \[[@pone.0233665.ref061]\], these macrolides have the potential to be the leading compounds for the production of agrochemicals against the cereal killer MoT.

Frequent application of commercial fungicides with site-specific modes of action, like strobilurins (QoI, quinone outside inhibitors) and triazoles, has resulted in the widespread occurrence of resistant mutant species in MoT \[[@pone.0233665.ref027], [@pone.0233665.ref028]\]. Resistance development in fungal population against fungicides prompted search for new, effective antifungal agents with alternate mode of action to protect wheat plants against this phytopathogenic fungus. Results from this study pertaining to the inhibitory ability of these macrolides should motivate agrochemical companies to consider these as candidates for commercial products with novel modes of action against the wheat blast fungus.

Conclusion {#sec016}
==========

Our findings show that oligomycin B and F from *Streptomyces* spp., suppress hyphal growth and asexual development of MoT, and inhibited wheat blast development on detached leaves of wheat. Field assessment of these macrolides is required to evaluate these metabolites as effective fungicides against wheat blast. Further research is also required to understand the mode of action and the structure-activity relations among oligomycins A-G against the devastating wheat killer, *M*. *oryzae Triticum*.

The authors are also thankful to Dr. Hartmut Laatsch of Georg-August University Goettingen, Germany, for kindly providing the oligomycins for this research. Our sincere thanks are due to Dr. Mahfuzur Rahman and Tahsin Islam Sakif of West Virginia University, USA for linguistic editing of this manuscript.
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Responses to the Reviewers Comments/Suggestions

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Our response:

Thank you for the encouraging comment.

Reviewer \#2: Partly

Our response:

Thank you for the comment.

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Our response:

Thank you for the encouraging comment.

Reviewer \#2: Yes

Our response:

Thank you for the encouraging comment.

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Our response:

Thank you.

Reviewer \#2: No

Our response:

Thank you for the comment. We have provided all the data underlying the findings described in our manuscript in Tables and Fugures.

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Our response:

Thank you for the encouraging comment.

Reviewer \#2: No

Our response:

Thank you for the comment. We have substantially revised the manuscript responding to the reviewer's suggestions to make the manuscript clearer, accurate, and unambiguous.

5\. Review Comments to the Author

Reviewer \#1: Chakraborty et al. showed the effects of two oligomycins on disease cycle of MoT. Although the antifungal effects of these molecules on the growth of M. grisea was shown before (ref 11), this manuscript includes their effects on disease phenotype including hyphae growth, conidiation, conidia mophology, and pathogenicity. In addition, there is urgent need to develop effective eradication methods because MoT is newly emerging on South Asia. Thus this manuscript is timely proper for publication on PLoS ONE. However, some points should be

clarified before publication.

Our response:

Many thanks for these encouraging comments.

One major point is about MIC. The present method can show relative antifungal activities only. But it is not proper for determination of MIC because only diffused oligomycins have effects on the edge of mycelium. We do not know exact amount of the effective molecules. For the exact MIC, the molecules should be included in the liquid or solid media. Or the authors can give up mentioning MICs in the manuscript.

Our response:

Thank you for this valuable comment. We have deleted the term MIC and also Figure 4 from the manuscript.

Figure 5 might be conidia but more magnified and clear images should be given. And the concentration on the figure is not matched to description (296-298) in the manuscript.

Our response:

Thank you for the comment. We have provided representative images of the conidia taken after 24 hrs of incubation by Zeiss Primo Star microscope at 40x magnification. The images demonstrated the gradual decrease of sporulation with the increasing concentrations of compounds.

Thank you for pointing out this erroneous placement of the images in the figure 5. We have revised Figure 5 for matching with the description (296-298) in the manuscript.

The quality of Fig 6 and 7 is not good.

Our response:

Thank you for this comment. We have provided representative images in Figure 6 and 7. We have replaced some images in Figure 6 for a better demonstration.

Figure 7B need to be drawn again scientifically.

Our response:

Thank you for this comment. We have drawn it scientifically.

Reviewer \# 2: Data support conclusions; they mostly do, however the \"discussion\" is very long and there are some statements that are not borne up by the data in the results.

Our response:

Thank you for this valuable comment. We have deleted redundant sentences from the discussion part to make it more precise.

Is data fully available; mostly, weak points have to do with no data for swollen hyphae and whether shorter or longer germs tubes should be quantified by measurements.

Our response:

Thank you for this comment. We have given the picturesque data of swollen hyphal cells in Figure 2 captured by a camera (ZEISS Axiocam ERc 5s) attached to the microscope at 100x magnification according to the reviewer's comment, and also described the data in the result portion of the manuscript. We have quantified shorter or longer germs tubes on the basis of observations.

Standard English needed a lot of work. I am afraid some of my editing may have changed the author\'s meaning because I was at times unsure what was being conveyed.

Our response:

Thank you for the comment. We sincerely appreciate the reviewer for the helpful tips and huge linguistic editing for the improvement of the manuscript. We have revised it substantially following your suggestions. We hope that you would have a pleasant experience in reading it now.

Additional editorial Comments/Suggestions

Line:

1: Title; the term pathotype has been used by other researchers for this taxon but it is not officially accepted; currently there is no formal acceptance of the taxon Magnaporthe oryzae triticum but this is evolving nomenclature. In any case I would not capitalize triticum. When taxa include the genera of plants in the binomial (or trinomial), they are not capitalized.

Our response:

With due respect with the reviewer comment, we would like to mention that a numbers of previous studies were based on Magnaporthe oryzae which published in reputed peer-reviewed journals. The authors of these studies used the pathotype name of M. oryzae with the capitalized Triticum. Here are some references for your kind consideration.

Pieck, M. L., Ruck, A., Farman, M. L., Peterson, G. L., Stack, J. P., Valent, B., & Pedley, K. F. (2017). Genomics-Based Marker Discovery and Diagnostic Assay Development for Wheat Blast. Plant Disease, 101(1), 103--109. doi:10.1094/pdis-04-16-0500-re

Gladieux, P., Condon, B., Ravel, S., Soanes, D., Maciel, J. L. N., Nhani, A., ... Fournier, E. (2018). Gene Flow between Divergent Cereal- and Grass-Specific Lineages of the Rice Blast Fungus Magnaporthe oryzae . mBio, 9(1). doi:10.1128/mbio.01219-17 

Yasuhara-Bell, J., Pedley, K. F., Farman, M., Valent, B., & Stack, J. P. (2018). Specific detection of the wheat blast pathogen (Magnaporthe oryzae Triticum) by loop-mediated isothermal amplification. Plant Disease. doi:10.1094/pdis-03-18-0512-re 

Gupta, D. R., Avila, C. R., Win, J., Soanes, D. M., Ryder, L. S., Croll, D., ... Islam, M. T. (2018). Cautionary Notes on Use of the MoT3 Diagnostic Assay for Magnaporthe oryzae Wheat and Rice Blast Isolates. Phytopathology. doi:10.1094/phyto-06-18-0199-le 

Tosa, Y., Tamba, H., Tanaka, K., and Mayama, S. 2006. Genetic analysis of host species specificity of Magnaporthe oryzae isolates from rice and wheat. Phytopathology 96:480-484.

14: "...and the oomycete Plasmopara viticola." The reference that this comes from only indicates activity against this particular oomycete, and you cannot assume all "peronosporomyctes" are equally affected. The author of the cited paper took excessive liberties in using the term peronosporomycetes.

Our response:

Thank you for this comment. We have revised it as per your suggestion.

21: omit "disease" here and in other places where it follows "wheat blast". Wheat blast is a disease so we don't have to indicate that it is a disease.

Our response:

Thank you for this comment. We have revised it as per your suggestion.

22: while the term "mycelia" continues to crop up in recent manuscripts, I am not in favor of its use. Mycelium is plural, so why pluralize it again? "Mycelia" may be appropriate when you are speaking of mycelium from several different isolates or a collection, like "mycelia of Basidiomycetes". You occasionally use the term "mycelium", be consistent and use mycelium throughout.

Our response:

Thank you for this critical comment. We have revised it as per your suggestion.

30: "process of conidial formation" I don't know what this means; state specifically what process you are talking about.

Our response:

Thank you for this comment. Here we used the term "process of conidia formation" in the place of "conidiogenesis". Conidiogenesis is the process by which conidia formation occurred in the mycelium under a certain environmental conditions. We have revised it.

95: "Most of the synthetic fungicides are harmful..." This is an overstatement and certainly references cited (25-26) would not support the statement since that was not the nature of their research. These references may make that claim but repeating the claim would not be acceptable since these research papers were not about demonstrating fungicides are harmful to humans.

Our response:

Thank you for the comment. We have revised the statement with appropriate references.

100: "Nowadays, natural products..." This is a spurious argument considering the fungicides that are used for wheat blast have an LD 50 that are well more than twice as high as the LD 50's of oligomycins. It's not good enough to simply state that natural products are safer than synthetic ones.

Our response:

Thank you for the comment. We have revised the sentence.

It is interesting to note that strobilurins are analogs of natural products.

Our response:

Thank you for the comment. Strobilurins are a group of natural products and their synthetic analogs which are are used in agriculture as fungicides (<https://en.wikipedia.org/wiki/Strobilurin>). We mentioned strobilurin as a synthetic commercial fungicide.

105: While this statement may be generally true, you are implying that this is true for oligomycins and there is no evidence that this is the case.

Our response:

Thank you for this comment. We have revised the statement.

131: "A pure culture of a single colony..." this is an odd statement; perhaps you meant, "A pure culture from a single spore."

Our response:

Thank you for pointing out the error. We have revised the sentence.

136: The references cited, 14-29 do not refer to using 500 ml water to remove aerial mycelium.

Our response:

Thank you for this comment. We have used the technique of conidia production from the cited references 14 and 29. We have slightly optimized the method and used 500 ml water for removing aerial mycelia from the MoT agar block properly.

150: perhaps the ethyl acetate should have been a control as well.

Our response:

Thank you for the comment. We have used filter paper disks treated with ethyl acetate in the control plate, as we used water as a positive control in all the experiments.

150: You need to state the "active ingredient" (a.i.) of these materials. Are the oligomycines 100% pure? The fungicide is not; see <https://www.cropscience.bayer.co.za/> en/Products/Fungicides/Nativo.aspx. I believe that the fungicide is 10 and 20% a.i. for the two components.

Our response:

Thank you for this comment. We have used 100% pure powder form of oligomycins in our experiments. We purchased Nativo 75WG from Bayer Crop Science Ltd. Dhaka, Bangladesh and the a.i. for the two components is Trifloxystrobin/Tebuconazole 25:50 % w/w.

151: state the volume of material that was loaded into the disks

Our response:

Thank you for this comment. We have poured 20 µl compound solutions per disk for each concentrations.

155: you should state the space difference between the paper disc and the mycelial plug.

Our response:

Thank you for this comment. We have placed the paper disk at the opposite side of the mycelial plug in the 9 cm diameters petri plate. We have maintained about 2 cm distance between the paper disc and the mycelial plug.

156-158: Rather than call Nativo a positive control, I would refer to it as the "industry standard".

Our response:

Thank you for this comment. We have revised it.

159: Earlier you referred to Nativo as a positive control and here you refer to it as a negative

control.

Our response:

Thank you for the comment. We have used filter paper disk loaded with water as a negative control. We have revised the sentence.

163: This is unclear. I think you mean that each treatment, and the controls were done in duplicate and the experiment was repeated five times.

Our response:

Thank you for pointing out the editing error of this sentence. We have used five replications for each treatment for every experiment and repeated all the experiments five times. We have revised the sentence for clear understanding.

164: Did you measure the radius or the diameter; most people measure the diameter. I think the term radial is ok but it's not clear what you measured.

Our response:

Thank you for the comment. We have measured the diameter of the fungal colony.

165: Since the colonies were not circular, you need to indicate where you took the measurements, in the middle of the colony? In the widest place? You measured in two directions, did you take the average? When I measure the growth in the figures in millimeters and did the math according to your equation, I came up with very different numbers. I probably measured differently than you.

Our response:

Thank you for the comment. We measured from two directions and took the average. We measured in centimeter with a meter ruler along with two perpendicular lines drawn on each plate\'s lower side.

170: To make these observations, did you make microscope mounts on slides? If from the petri dish did you observe through the top or the bottom of the dish? Did you use oil with the 100X lens?

Our response:

Thank you for the comment. We have observed through the bottom of the dish. We used oil immersion with the 100X lens.

170-172: "Hyphal morphology at the vicinity of compounds was observed..." and "...and images of morphological features of hyphae were recorded..." This needs to be clarified. I think you are saying. "Hyphal morphology at the leading edge of the colonies facing the treated and control discs were observed with a Zeiss Primo Star microscope at 40X and 100X. (you need to say how you did this, for example 100x is an oil emersion lens). Macro images of the disc diffusion experiment were captured with a Canon DOS 700D digital camera. Images of the hyphae were captured with a Zeiss Axiocam ERc 5s through the microscope." I don't know if I am describing your work correctly.

Our response:

Many thanks for describing our work appropriately. We have revised it.

184: Early you stated that washing the cultures was to remove aerial mycelium and here you say it was to reduce nutrients. And, the same references are used. I do not believe either reference is appropriate for this technique. Please re-read these references to be sure. Also, you need to be consistent as to why you washed the cultures.

Our response:

Thank you for the query. For MoT conidia production, we used mycelial blocks from an untreated 5 days-old MoT fungus Petri plate and washed out the mycelia from the PDA agar blocks for washing out nutrient which is essential for conidia production according to this protocol.

189: If you are going to say "optimum humidity and lights" then it implies that you know the humidity and light and you should express what it is; otherwise don't mention it was optimum.

Our response:

Thank you for this comment. We have revised the sentence by adding the optimum humidity and lights (\>90% RH and 14 h light followed by 10 h of darkness) requirement for sporulation according to our protocol.

210: Did you pipette the conidia onto a microscope slide and use a coverglass and oil-emersion? You need to explain exactly how you carried this out. The quality of the images in Figure 6 do not look like they were taken at 100X under oil. Also, it is troubling that the field of view shown varies considerably with regard to spore concentration. Spore germination can be affected by the concentration of spores. I realize the concentration was the same, but the Figure 6 shows few spores. It would have been better to selectively image the various stages (shown in Table 1) under oil with high quality images.

Our response:

Thank you for the comment. We have pipetted the conidia onto a microscope slide and use a cover glass and oil-emersion. We used the same concentration of spores and we have provided representative images of various stages of conidia development. We have replaced some images according to the reviewer comment.

230: Describe the plates

Our response:

Thank you for the query. We have used sterile Sarstedt polystyrene square Petri plates (100 x 100 x 20 mm).

232: Did you inoculate 3 leaves for each treatment?

Our response:

Thank you for the query. We used 5 leaves for each treatment.

233: Was the leaf where the solution was placed, dry after 15 minutes?

Our response:

Thank you for the comment. We left the leaves to dry the solution for 15 minutes.

234: 1 × 105 conidia/ml? or per 1 microliter?

Our response:

Thank you for the comment. We used ca. 1 × 105 conidia per 1 mililiter.

268: Why is there a reference to Dame et al.? Are the figures from a paper of his?

Our response:

Thank you for the comment. We have redrawn the chemical structures described in Dame et al.

269: and Figure 2a: It appears that the inoculum and the control disc were placed next to each other; please explain.

Our response:

Thank you for the query. There were specific distance remains between the inoculum and the disk, but after the full growth of the fungus, it seems like they are placed next to each other.

308: I don't see what is being described by "...destruction of regular growth with twisted ridges and corrugations, and irregular swelling of hyphal cells." You must use some other descriptors; I can see differences but not twisted ridges and corrugations. Also, I do not see swelling of hyphal cells in the figures. Did you measure them?

Our response:

Thank you for the query. We observed under the light microscope at 100X magnification that oligomycins inhibited the regular circular hyphal growth of MoT by twisting and corrugating the ridges of hyphae. We also noticed irregular swelling of some hyphal cells. We have added images of swelling of hyphal cells in the figure taken at 100X magnification.

310: I don't see the crystals in the Nativo figure, or the twisted ridges and corrugations. I am not sure I can see "loss of polar growth". How does it grow without polar growth?

Our response:

Thank you for the query. We used the term 'Crystal' to describe the state of appearance of suppressed MoT hyphae by Nativo. Like oligomycins, Nativo also inhibited the hyphal growth of MoT by twisting and corrugating the ridges of hyphae. By the statement 'loss of polar growth', we meant that Nativo has arrested the normal polar growth of MoT hyphae. We have replaced the Figure 2(d) for better representation.

323: Figure 5. I can't tell much from these figures. It is hard to justify them if they do not show what they need to show. Perhaps my copies are not very good.

Our response:

Thank you for pointing out this erroneous placement of the images in the figure. We have rearranged the images for better understanding. The images demonstrated the gradual decrease of sporulation with the increasing concentrations of compounds. Fig 5(a) represented huge sporulation in the control mycelial agar block, 5(b) represented gradual decrease in conidia production with increasing concentration of Oligomycin B; 5(c) and 5(d) represented gradual decrease in conidiogenesis with increasing concentration of Oligomycin F and Nativo. At 100 µg/ml, conidia production was zero in all the cases.

366: Do you mean that after the first 6 hours of germination, 14.3% had lysed? If so, I would write. "...and 14.3± 0.7% of the germ tubes lysed within the first 6 hr of incubation."

Our response:

Many thanks for the correction. Yes, we mean it. We have revised it.

365 and 371 and Figure 6: Does "short" mean shorter than the control? Or does it mean normal? If it was shorter than the control, add "...shorter than the control". You might add "approximately by half or a third", or some other figure. Also, for figure 6, it would have been helpful to point out normal, short, long and appressoria in the figures. Unfortunately, the figures are of poor quality and do not show very well the differences. Since the counts and statistics were done on the observations, it was not necessary to take random pictures of the microscopic field; would have been better to selectively take images at higher magnifications illustrating the above differences in morphology.

Our response:

Many thanks for the corrections. It means shorter than control. We have revised the sentence. We have pointed out the normal, short, elongated and appressoria in the figures according to your suggestion. We have replaced some images for clear presentation.

379-380: "...but a slower growth of germ tubes..." This is the same thing as "short germ tubes", right? If so, use the same descriptions for all three treatments.

Our response:

Thank you for pointing out the confusion generating sentence. We have revised the sentence.

382: It is not necessary to have (MoT) in the figure text since you will not refer to it again in the figure text.

Our response:

Thank you for the comment. We have revised it.

388-399: The subtitle as written is biased (as are some of the others in the results); it emphasizes the oligiomycins when the experiments are a comparison of a fungicide with the oligomycins.

Our response:

Thank you for this comment. We have revised it according to reviewer's comment.

407 (Fig. 7) It needs to be indicated on the figure which leaves are represented by 5, 10 and 100 milligrams. You may also mention that "a representative leaf of five replicates"

Our response:

Thank you for the query. We have labelled below the images with each concentrations. We have revised it according to your suggestion.

423-427: Redundant sentences

Our response:

Thank you for the comment. We have deleted the sentences according to your suggestions.

435: It may be over-reaching to use the term "potential" without considering the possible economic cost of the application. Perhaps a bit of math may shed some light on this.

Our response:

Thank you for the comment. Here we used the term 'potential' to state about the effectiveness of the compounds to suppress MoT on detached wheat leaves.

439: Were these studies actually on the development of plant disease protection products?

Our response:

Thank you for this comment. We have reported some secondary metabolites against the wheat blast fungus to consider them as candidates for producing/developing commercial plant protection products (i.e., fungicides) with novel modes of action.

444: I cannot see any evidence of swelling in Fig 2b and 2c. This should have been quantified by measurements and imaging of single hyphae. In the figure, where hyphae appear to be wider, it could easily be an artifact of the hyphae being close together. It should be a simple matter to treat some colonies, do the measurements and take new images of hyphae.

Our response:

Thank you for this query. We have found swelling of MoT hyphal cells under light microscope at 100X magnification, which we did not demonstrate. We have added the figures of swelling hyphal cells for better understanding.

445: this statement requires a reference or two.

Our response:

Thank you for the comment. We have addressed the statement with appropriate references.

446: what would have been the micrograms per ml?

Our response:

Thank you for the query. We have used a range of concentrations from 0.25 to 100 µg/ml. We loaded 20 µl of compounds solution in filter paper disk for each treatment.

447: no data has been presented to show that increasing conc. Increases the dia of the hyphae

Our response:

Thank you for this comment. It was our observation but we did not present it in this paper. We have revised the sentence.

466: it is not clear that reduced conidiogenesis would occur on wheat leaves.

Our response:

Thank you for this query. We have given this statement on the basis of in vitro experiment. A further study is needed to confirm it on wheat leaves.

472: you need to add arrows to the Fig to help this statement

Our response:

Thank you for the comment. We have added arrows in the Figure according to your suggestion.

482: No data was presented to support this statement. There may be a different was of bringing this idea forward.

Our response:

Thank you for this comment. We have deleted the statement, as it produced confusion.
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Dear Dr. Islam,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript is much improved. Reviewer 1 could not critique the revised version of the paper, but my assessment is that their comments were adequately addressed. Reviewer 2 has additional comments and corrections to the manuscript that should be considered by the authors in a second round of revisions.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Richard A Wilson

Academic Editor

PLOS ONE
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**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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28 Jul 2020

Response to the Comments of Reviewers and Editor

Dear Editor,

We have revised the manuscript carefully addressing the queries/suggestions/comments of the reviewers, and uploaded a blue-inked marked version and a clean version. Here is our point by point responses to the reviewer's comments.

Comments to the Author

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Our response:

Many thanks for this encouraging comment.

Reviewer \#2: (No Response)

2\. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer \#2: Partly

Our response:

Thank you for your kind comment.

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Our response:

Thank you for the encouraging comment.

4\. Have the authors made all data underlying the findings in their manuscript fully available?

Reviewer \#2: Yes

Our response:

Thank you for this encouraging comment.

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

Reviewer \#2: Yes

Our response:

Thank you for the encouraging comment.

Comments by line

264-266: I think I know what you are saying here, unfortunately the images don't show very well what you are describing. If possible, grow the fungus on these materials and then mount the hyphae on a glass slide and take images under oil at 100X.

Our response:

Thank you for the comment. For your kind observation and understanding, we have enclosed below two images of swelling of MoT hyphal cells under the effect of oligomycin B and F that were taken at 100X under oil, for your kind consideration. Due to COVID-19, our university and laboratories are under lockdown, and hence, it is difficult for us to conduct further experiment in this pandemic condition.

I will try to write this sentence differently, but I don't want to change the meaning.

"Hyphae treated with oligomycin B and F showed irregular growth and an increase in branch frequency per unit length of hyphae. The hyphal cell walls were not smooth but showed ridges giving a corrugated appearance and irregular swelling of cells (Fig 2b and 2c)."

Our response:

Thank you for this valuable suggestion for the improvement of the manuscript. We have revised the text accordingly.

268: you do not need to repeat the description of the hyphae since you said it was essentially the same. I do not know what you mean by crystals, but it is probably the wrong word. I cannot help you with that because I don't see anything that resembles crystals in the figure.

Our response:

We agree with your valuable suggestion. Thank you. We have revised it according to your suggestion. We have deleted the confusing term 'crystal' for clarification.

270: The only difference I see in the description of the hyphae are "crystals". Did crystals develop in the culture medium, or the hyphae?

Our response:

Thank you for this critical and important comment. There was no real crystals developed in the culture medium, or the hyphae. We used the term 'Crystal' to describe the state of appearance of suppressed MoT hyphae by Nativo. However, we have deleted this confusing/inappropriate term 'crystal' and revised the manuscript accordingly.

274-282: This paragraph is very awkward. And I cannot tell much by the pictures. I gather that the dark areas are clusters of conidia. The 5 microgram images appear out of focus. There seems to be more conidia in the 5 microgram images which is a good thing. At 100 micrograms there is a lot of hyphae which does not show up in the other images, why is that? Is the picture taken at a different plane of focus? That would explain the differences. You would not expect much hyphae growth in 24 hr. so that must be background hyphae. It would have been better not to have focused on the hyphae because it is distracting and a bit misleading. The control does not appear to have hyphae either. You need to discuss the differences in these images.

Our response:

Thank you for pointing out the weakness of the paragraph. We stated before that Figure 4 represents the gradual decrease of conidia production with the increasing concentrations of the tested compounds. Yes, the dark areas are the clusters of conidia. We have replaced the 5 microgram image of oligomycin F with a clear one for better representation.

The 100 micrograms images represent the existence of broken mycelial tips with no sign of conidiophore and conidial growth on the surface of the agar block treated with macrolides and Nativo. There was not any hyphal growth occurred after the treatment of macrolides and Nativo at 100 µg/ml. Yes, we have taken the picture in slightly different plane of focus as the conidia produces on the conidiophore on the upper side of the hyphae. However, we have replaced the images with same plane of focus for better representation.

I assume (and the images in Fig 4 seem to show it) that for both the oligomycins and the fungicide, there is inhibition correlated with dose. If this is true, then maybe the following paragraph will be clearer. I am assuming that conidiogenesis and formation of conidia mean the same thing.

Inhibition of conidiogenesis

Conidial formation by MoT was remarkable decreased by the oligomycins and the fungicide at 5 and 10 µg/ml when compared to the control, and inhibition increased with an increase in concentration from 5, 10 and 100 µg/ml (Fig 4). For all three treatments, no conidia developed at 100 µg/ml. Microscopic examination revealed burst mycelial tips, and a complete lack of conidiophores for all three treatments at 100 µg/ml.

Our response:

Thank you for kind and valuable suggestions for the improvement of the manuscript. We have revised the paragraph accordingly.

315: the sentence as written is a little unclear. Since there was no germination, obviously there could not be germ tubes or mycelial growth. Simplify.

"It is interesting that the oligomycins produced abnormally long or short germ tubes and branching and lysing while the fungicide did not result in these changes."

Our response:

Thank you for your kind suggestion. We have revised it as per your suggestion.

350-352: based on Fig. 6A the opposite appears to be true. I would write "At 5 µg/ml the fungicide suppressed lesion development more than both oligomycins. At 10 µg/ml the fungicide showed more suppression than oligomycin F. No lesions developed with any of the three treatments at 100 µg/ml.

Our response:

Thank you for correcting and revising the sentences. We have revised these sentences.

383: How was o-F 10-fold stronger than Nativo? How was the calculation made? Fig. 6A shows the fungicide more effective (shorter lesions) than o-F.

Our response:

Thank you for the query. In bioassay, we have found that oligomycin F was 10-fold stronger than Nativo in terms of mycelial growth inhibition, where the minimum inhibitory concentration of oligomycin F and Nativo were 0.005 and 0.05 μg/disk, respectively. We have revised the sentence for better understanding.

409: Not sure of the relevancy of this statement. For this kind of pathogen you have spore germination, germ tube, appressorium, infection and then hyphae development the host.

Our response:

Thank you for the comment.

452-454: scale was not mentioned or defined in the text so hear it is confusing. I would delete this section as it is redundant.

Our response:

Thank you for the comment. We have revised it according to your suggestion.

458-459: this is not what Fig 6B shows

Our response:

Thank you for pointing out an error. We have revised it.

481-484: this is an overstatement and should be deleted.

Our response:

Thank you for the kind suggestion. We have deleted the statement.

We sincerely appreciate the knowledgeable reviewer for valuable editorial comments for the improvement of the manuscript.

A revised version mentioning the changes in blue-ink and a clean version were uploaded for the find perusal and consideration.

We hope that this revised version (R2) will be accepted for publication in the PLOS ONE.

Kind regards,

Dr. Md Tofazzal Islam, FBAS

(Fellow of Fulbright, Commonwealth, JSPS and Alexander von Humboldt Foundation)

Professor and Director, Institute of Biotechnology and Genetic Engineering (IBGE),

Bangabandhu Sheikh Mujibur Rahman Agricultural University, Gazipur-1706

BANGLADESH

Tel. +88-02-9205310-14 Extn. 2252

Fax: +88-02-9205333

Cell: +88-0171-4001414, +88-01534568893

<http://www.btlbsmrau.org>

<http://www.researchgate.net/profile/Md_Tofazzal_Islam>

<http://orcid.org/0000-0002-7613-0261>
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Dear Dr. Islam,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Richard A Wilson

Academic Editor

PLOS ONE
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Oligomycins Inhibit Magnaporthe oryzae Triticum and suppress wheat blast disease

Dear Dr. Islam:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Richard A Wilson

Academic Editor

PLOS ONE
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